Harmony Biosciences Holdings Stock Story

HRMY Stock  USD 33.28  0.24  0.72%   
Slightly above 55% of Harmony Biosciences' investor base is interested to short. The analysis of overall sentiment of trading Harmony Biosciences Holdings stock suggests that many investors are impartial at this time. Harmony Biosciences' investor sentiment overview provides quick insight into current market opportunities from investing in Harmony Biosciences Holdings. The current market sentiment, together with Harmony Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Harmony Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Harmony Biosciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Harmony daily returns and investor perception about the current price of Harmony Biosciences Holdings as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Harmony Biosciences Holdings.

Harmony Biosciences Latest Timeline

Harmony Biosciences is listed for 33.28. About 19.0% of the company shares are held by company insiders. The book value of Harmony Biosciences was currently reported as 8.23. The company has Price/Earnings (P/E) ratio of 293.37. Harmony Biosciences had not issued any dividends in recent years.
When determining whether Harmony Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harmony Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harmony Biosciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harmony Biosciences Holdings Stock:

Complementary Tools for Harmony Stock analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.43)
Earnings Share
2.13
Revenue Per Share
9.787
Quarterly Revenue Growth
0.313
Return On Assets
0.1616
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.